2020
DOI: 10.1016/j.bbrep.2020.100747
|View full text |Cite
|
Sign up to set email alerts
|

A correlation between BCL-2 modifying factor, p53 and livin gene expressions in cancer colon patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 24 publications
0
8
0
Order By: Relevance
“…We filled this research gap by constructing a prognosis risk score model based on four mitochondria-related genes. Besides its role in BRCA, BMF is also an important prognostic marker for patients with other cancers, such as colon cancer [ 20 ] and hepatocellular carcinoma [ 21 ]. MRPL36 is a mitochondrial ribosomal protein that has not been studied in BRCA, but MRPL36 has been correlated with poor progression-free survival in ovarian cancer [ 22 ].…”
Section: Discussionmentioning
confidence: 99%
“…We filled this research gap by constructing a prognosis risk score model based on four mitochondria-related genes. Besides its role in BRCA, BMF is also an important prognostic marker for patients with other cancers, such as colon cancer [ 20 ] and hepatocellular carcinoma [ 21 ]. MRPL36 is a mitochondrial ribosomal protein that has not been studied in BRCA, but MRPL36 has been correlated with poor progression-free survival in ovarian cancer [ 22 ].…”
Section: Discussionmentioning
confidence: 99%
“…Badr et al reported that upregulation of livin and downregulation of BMF and p53 expression are signi cantly correlated with more tumor aggressiveness (advanced TNM stage), making metastasis progress more rapidly, and decreasing overall survival in colon cancer patients. Thus, we can apply these genes as crucial prognostic markers related to poor results [37]. Another research showed that STARD13 3′UTR could play as a ceRNA for BMF to enhance apoptosis and be used as a potential therapeutic target in breast cancer cells [38].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, livin can also induce the production of specific CD4 + T cells and CD8 + T cells [14]. Most of the previous studies on livin focused on the pathogenesis of tumor, such as the relationship between livin expression and the pathogenesis and prognosis of colon cancer and nasopharyngeal carcinoma [24,25]. Recent reports depicted that stronger expression of livin in the pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP).…”
Section: Discussionmentioning
confidence: 99%